Abrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 антитело fragment that binds to IL-13. Abrezekimab prevents связывание to the IL-13Rα1 subunit. Abrezekimab can be used in research of asthma.
Abrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. Abrezekimab can be used in research of asthma.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.